Park, K. S., Kwak, S., Cho, Y. M., Park, K. S., Jang, H. C., Kim, S. Y., & Jung, H. S. (2016). Vildagliptin reduces plasma stromal cell‐derived factor‐1α in patients with type 2 diabetes compared with glimepiride. J Diabetes Investig.

Park, Kyeong Seon, SooHeon Kwak, Young Min Cho, Kyong Soo Park, Hak C. Jang, Seong Yeon Kim, and Hye Seung Jung. "Vildagliptin Reduces Plasma Stromal Cell‐derived Factor‐1α in Patients With Type 2 Diabetes Compared With Glimepiride." J Diabetes Investig 2016.

Park, Kyeong Seon, et al. "Vildagliptin Reduces Plasma Stromal Cell‐derived Factor‐1α in Patients With Type 2 Diabetes Compared With Glimepiride." J Diabetes Investig 2016.